Sai Life Science Limited works with innovative pharma and biotech companies by providing services across drug discovery, development, and manufacturing of small-molecule new chemical entities (NCE). The company uses its scientific knowledge and skills to deal with critical healthcare challenges. Their services can be customized according to the customer’s needs, whether it’s a small client, a large biotech company, or a global pharmaceutical company making them adaptable and unstoppable. They are growing more in CRDMO than their competitors by earning revenue CAGR (Compound Annual Growth Rate) and EBITDA CAGR from fiscal year 2022 to 2024.
Sai Life Sciences IPO open date is December 11, 2024 and the IPO will close on December 13, 2024. Sai Life Sciences IPO is a Book Built Issue. The company to raise around ₹3,042.62 crores via IPO that comprises fresh issue of ₹3,042.62 crores and offer for sale up to 38,116,934 equity shares with face value of ₹1 each.
Sai Life Sciences IPO price band is ₹522 to ₹549 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Sai Life Sciences IPO to list on BSE, NSE on December 18, 2024. The company reported Profit of ₹82.81 crores in 2024 against Profit of ₹9.99 crores in 2023. As per the financials the IPO investors should apply the IPO for a long term.
Sai Life Sciences IPO Details
| IPO Open Date: | December 11, 2024 |
| IPO Close Date: | December 13, 2024 |
| Face Value: | ₹1 Per Equity Share |
| IPO Price Band: | ₹522 to ₹549 Per Share |
| Issue Size: | Approx ₹3,042.62 Crores |
| Fresh Issue: | Approx ₹950.00 Crores |
| Offer for Sale: | Approx 38,116,934 Equity Shares |
| IPO Listing: | BSE & NSE |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
Sai Life Sciences IPO Timeline
The Sai Life Sciences IPO date is December 11 and the close date is December 13. The Sai Life Sciences IPO allotment will be finalized on December 16 and the IPO listing on December 18.
| IPO Open Date: | December 11, 2024 |
| IPO Close Date: | December 13, 2024 |
| Basis of Allotment: | December 16, 2024 |
| Refunds: | December 17, 2024 |
| Credit to Demat Account: | December 17, 2024 |
| IPO Listing Date: | December 18, 2024 |
Sai Life Sciences IPO Lots
| IPO Activity | Date |
|---|---|
| Issue Price | ₹522.00-549.00 |
| Market Lot: | 27 Shares |
| 1 Lot Amount: | ₹14823 |
| Min Small HNI Lots(2-10 Lakh): | 378 shares (14 lots) – ₹207522 |
| Min Big HNI Lots(10+ Lakh): | 1836 shares (68 lots) – ₹1007964 |
Sai Life Sciences Limited: Financial Overview and Key Data
Sai Life Sciences Limited’s revenue increased by 20% and profit after tax (PAT) rose by 729% between the financial year ending with March 31, 2024 and March 31, 2023.
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 2,476.78 | 2,275.14 | 2,186.65 | 2,164.23 |
| Revenue | 693.35 | 1,494.27 | 1,245.11 | 897.74 |
| Profit After Tax | 28.01 | 82.81 | 9.99 | 6.23 |
| Net Worth | 1,044.75 | 974.34 | 887.29 | 877.76 |
| Reserves and Surplus | 1,025.44 | 953.99 | 867.43 | 859.17 |
| Total Borrowing | 764.49 | 710.16 | 699.23 | 751.32 |
